Pinealon – 10 mg Research Compound

Pinealon (10mg) — Research Compound

Pinealon is a synthetic tripeptide research compound derived from the pineal gland’s regulatory proteins. It is studied for its ability to cross the blood-brain barrier and interact with the circadian rhythm and neuronal protein synthesis pathways. Researchers investigate Pinealon for its potential to modulate cellular ageing within the central nervous system and its role in protecting neurons from oxidative stress-induced damage.

Findings from early-stage clinical trials have reported:

• Improved adaptation to changing environmental factors and stressors observed in experimental models
  
• Alterations in the expression of genes associated with circadian rhythm regulation reported
  
• Enhancements in cognitive markers and short-term memory retention noted in animal studies
  
• Protective effects against free-radical damage in neuronal tissue observed in-vitro
  

Researchers study Pinealon to explore its utility in supporting neuro-regeneration and biological clock synchronisation. By focusing on the peptide’s interaction with DNA methylation and protein expression, it serves as a valuable tool for investigating longevity and the mitigation of age-related cognitive decline. Its unique ability to penetrate the blood-brain barrier makes it a focal point for research into central nervous system stability.

Available Formats:
This compound is available as a vial of lyophilised powder, or can be ordered in a disposable pen, a reusable pen, or a cartridge for an existing reusable pen system.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use